Tonix Pharmaceuticals Holding Corp (TNXP)
0.1683
+0.01
(+5.19%)
USD |
NASDAQ |
Apr 26, 16:00
0.17
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Operations (Quarterly): -22.34M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.34M |
| September 30, 2023 | -23.38M |
| June 30, 2023 | -23.37M |
| March 31, 2023 | -32.91M |
| December 31, 2022 | -22.30M |
| September 30, 2022 | -23.54M |
| June 30, 2022 | -21.17M |
| March 31, 2022 | -31.05M |
| December 31, 2021 | -22.44M |
| September 30, 2021 | -12.95M |
| June 30, 2021 | -19.11M |
| March 31, 2021 | -21.06M |
| December 31, 2020 | -13.91M |
| September 30, 2020 | -15.28M |
| June 30, 2020 | -10.04M |
| March 31, 2020 | -9.326M |
| December 31, 2019 | -6.683M |
| September 30, 2019 | -6.645M |
| June 30, 2019 | -4.713M |
| March 31, 2019 | -8.642M |
| December 31, 2018 | -6.824M |
| September 30, 2018 | -4.891M |
| June 30, 2018 | -5.485M |
| March 31, 2018 | -6.771M |
| December 31, 2017 | -4.927M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.047M |
| June 30, 2017 | -4.36M |
| March 31, 2017 | -4.794M |
| December 31, 2016 | -5.441M |
| September 30, 2016 | -8.392M |
| June 30, 2016 | -7.995M |
| March 31, 2016 | -15.48M |
| December 31, 2015 | -11.91M |
| September 30, 2015 | -12.32M |
| June 30, 2015 | -9.238M |
| March 31, 2015 | -9.053M |
| December 31, 2014 | -8.218M |
| September 30, 2014 | -4.859M |
| June 30, 2014 | -5.699M |
| March 31, 2014 | -4.064M |
| December 31, 2013 | -3.531M |
| September 30, 2013 | -2.863M |
| June 30, 2013 | -0.761M |
| March 31, 2013 | -1.362M |
| December 31, 2012 | -1.505M |
| September 30, 2012 | -1.300M |
| June 30, 2012 | -1.130M |
| March 31, 2012 | -1.778M |
| December 31, 2011 | -1.467M |
| September 30, 2011 | -0.5585M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-32.91M
Minimum
Mar 2023
-4.713M
Maximum
Jun 2019
-18.01M
Average
-21.06M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 85.39M |
| PetVivo Holdings Inc | -1.290M |
| Acurx Pharmaceuticals Inc | -4.198M |
| Kezar Life Sciences Inc | -18.98M |
| Allakos Inc | -24.27M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.431M |
| Cash from Financing (Quarterly) | 40.71M |
| Free Cash Flow | -109.90M |
| Free Cash Flow Per Share (Quarterly) | -0.3886 |
| Free Cash Flow to Equity (Quarterly) | -31.69M |
| Free Cash Flow Yield | -2.76K% |